Upgrade to SI Premium - Free Trial

Bath & Body Works (BBWI) Appoints Steve Voskuil to its Board

February 21, 2023 4:16 PM

Bath & Body Works, Inc. (NYSE: BBWI) announced today that Steve Voskuil, currently Senior Vice President and Chief Financial Officer at The Hershey Company, has been appointed as a new independent member of the Company’s Board of Directors. Mr. Voskuil is a highly accomplished executive with over 30 years of experience who brings global consumer products expertise and strong financial and capital allocation experience to further strengthen the diverse set of skills and experiences represented on the Board.

Sarah Nash, Board Chair, commented, “We are very pleased to welcome a finance leader of Steve’s caliber as the newest director on our Board. He brings deep knowledge of the global consumer products industry as well as substantial expertise in leading financial operations that spans from oversight of capital allocation and investment to technology infrastructure transformation. We are confident the Company and Board will benefit from his insights across areas directly relevant to our business as we advance our efforts to drive long-term value creation and position Bath & Body Works for the future.”

Mr. Voskuil said, “Bath & Body Works is an industry leader with strong growth prospects, and I am thrilled to join its Board as a new independent director. I look forward to leveraging both my financial and industry expertise in collaboration with the Board and management team to help advance the Company’s strategic initiatives and deliver enhanced value for shareholders.”

Mr. Voskuil’s appointment to the Bath & Body Works Board follows the recently announced appointment of Lucy Brady, President, Grocery & Snacks at Conagra Brands, as an independent director. With these two new directors, the Board now comprises 12 directors, 11 of whom are independent and seven of whom are members of diverse communities: female, people of color and/or LGBTQIA+.

About Steve VoskuilMr. Voskuil has served as Senior Vice President and Chief Financial Officer for The Hershey Company since 2019 and is responsible for leading its global finance organization, including financial planning and analysis, accounting and reporting, tax, treasury, internal audit and investor relations.

Mr. Voskuil joined Hershey from Avanos Medical (previously Halyard Health), a global medical device company serving healthcare needs in more than 90 countries, where he served as Chief Financial Officer since 2014. Mr. Voskuil was Senior Vice President and Chief Financial Officer for Avanos/Halyard for four years where he helped lead its successful spin-off from Kimberly-Clark Corporation as a public company.

Before Avanos/Halyard Health, Mr. Voskuil worked for 23 years at Kimberly-Clark Corporation, including serving as Vice President of Finance for Kimberly-Clark International and Vice President and Treasurer of Kimberly-Clark Corporation. In his various leadership roles at Kimberly-Clark Corporation, he gained deep experiences across finance, operational management, international and transformative leadership.

ABOUT BATH & BODY WORKS:Home of America’s Favorite Fragrances®, Bath & Body Works is a global leader in personal care and home fragrance, including the #1 selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Powered by agility and innovation, the company’s predominantly U.S.-based supply chain enables the company to deliver quality, on-trend luxuries at affordable prices. Bath & Body Works serves and delights customers however and wherever they want to shop, from welcoming, in-store experiences at more than 1,785 company-operated Bath & Body Works locations in the U.S. and Canada and more than 390 international franchised locations to an online storefront at bathandbodyworks.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995We caution that any forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) contained in this press release or made by our company or our management involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Words such as “estimate,” “project,” “plan,” “believe,” “expect,” “anticipate,” “intend,” “planned,” “potential” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, in some cases have affected and in the future could affect our financial performance and actual results and could cause actual results to differ materially from those expressed or implied in any forward-looking statements included in this press release or otherwise made by our company or our management:

We are not under any obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. Additional information regarding these and other factors can be found in “Item 1A. Risk Factors” in our 2021 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission (the “SEC”), and our subsequent filings.

Important Additional InformationBath & Body Works, Inc. (the “Company”) intends to file a proxy statement and WHITE proxy card with the SEC in connection with the solicitation of proxies for the Company’s 2023 Annual Meeting of Stockholders (the “Proxy Statement” and such meeting the “Annual Meeting”). The Company, its directors and certain of its executive officers will be participants in the solicitation of proxies from shareholders in respect of the Annual Meeting. Information regarding the names of the Company’s directors and executive officers and their respective interests in the Company by security holdings or otherwise are set forth in the Company’s proxy statement for the 2022 Annual Meeting of Stockholders, filed with the SEC on March 31, 2022 (the “2022 Proxy Statement”). To the extent holdings of such participants in the Company’s securities have changed since the amounts described in the 2022 Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Changes in Beneficial Ownership on Form 4 filed with the SEC. Additional information can also be found in the Company’s quarterly reports on Form 10-Q, filed with the SEC on November 30, 2022, September 2, 2022 and June 2, 2022. Details concerning the nominees of the Company’s Board of Directors for election at the Annual Meeting will be included in the Proxy Statement. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SHAREHOLDERS OF THE COMPANY ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, INCLUDING THE COMPANY’S DEFINITIVE PROXY STATEMENT AND ANY SUPPLEMENTS THERETO BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and shareholders will be able to obtain a copy of the definitive Proxy Statement and other documents filed by the Company free of charge from the SEC’s website, www.sec.gov. The Company’s shareholders will also be able to obtain, without charge, a copy of the definitive Proxy Statement and other relevant filed documents by directing a request by mail to Bath & Body Works, Inc., Attention: Investor Relations, Three Limited Parkway, Columbus, Ohio 43230, or from the Company’s website, www.bbwinc.com.

For further information, please contact:

Bath & Body Works, Inc.:Investor Relations Heather Hollander [email protected] Media Relations Tammy Roberts Myers [email protected]

Primary Logo

Source: Bath & Body Works, Inc.

Categories

Board Changes Corporate News

Next Articles